{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:16:52Z","timestamp":1791605812995,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.anai.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:02:15Z","timestamp":1424476935000},"page":"281-288.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Critical appraisal of androgen use in hereditary angioedema: a\u00a0systematic review"],"prefix":"10.1016","volume":"114","author":[{"given":"Marc A.","family":"Riedl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2015.01.003_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2500\/aap.2013.34.3623","article-title":"HAE update: epidemiology and burden of disease","volume":"34","author":"Bernstein","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2015.01.003_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","article-title":"US hereditary angioedema association medical advisory board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency","volume":"1","author":"Zuraw","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2015.01.003_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.01.003_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.01.003_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib6","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2015.01.003_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2010.01.024","article-title":"Economic costs associated with acute attacks and long-term management of hereditary angioedema","volume":"104","author":"Wilson","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2015.01.003_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anai.2013.07.012","article-title":"Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life in 193 French patients","volume":"111","author":"Bouillet","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A\u00a0UK audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/aap.2013.34.3624","article-title":"HAE update: determining optimal patient specific therapy","volume":"34","author":"Gower","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2015.01.003_bib12","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.clinthera.2008.12.021","article-title":"Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema","volume":"30","author":"Birjmohun","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2015.01.003_bib13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2015.01.003_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-86-3-306","article-title":"Methyltestosterone therapy in hereditary angioedema","volume":"86","author":"Sheffer","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anai.2015.01.003_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0091-6749(80)90181-5","article-title":"Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema","volume":"65","author":"Agostoni","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2362.2010.02402.x","article-title":"Long-term efficacy of danazol treatment in hereditary angioedema","volume":"41","author":"F\u00fcst","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.anai.2015.01.003_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7326\/0003-4819-93-6-809","article-title":"Long-term therapy of hereditary angioedema with danazol","volume":"93","author":"Hosea","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anai.2015.01.003_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2265.2006.02704.x","article-title":"Treatment of hereditary angioneurotic oedema (HANE) with tibolone","volume":"66","author":"Ott","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.anai.2015.01.003_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-3083.2000.00652.x","article-title":"Impaired human ovarian follicular fluid complement function in hereditary angioedema","volume":"51","author":"Perricone","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib20","first-page":"499","article-title":"Hereditary angioneurotic edema and its correction with androgen therapy","volume":"16","author":"Rosen","year":"1980","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.anai.2015.01.003_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-9343(79)91184-7","article-title":"Prophylaxis of attacks of hereditary angioedema","volume":"66","author":"Rothbach","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.anai.2015.01.003_bib22","first-page":"13","article-title":"Hereditary and acquired angioedema: experience with patients in Puerto Rico","volume":"23","author":"Santaella","year":"2004","journal-title":"P\u00a0R Health Sci J"},{"key":"10.1016\/j.anai.2015.01.003_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0091-6749(79)90144-1","article-title":"Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema","volume":"64","author":"Sheffer","year":"1979","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-6749(81)90181-0","article-title":"Clinical and biochemical effects of stanozolol therapy for hereditary angioedema","volume":"68","author":"Sheffer","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0091-6749(87)80277-4","article-title":"Hereditary angioedema: a decade of management with stanozolol","volume":"80","author":"Sheffer","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib26","first-page":"318","article-title":"Hereditary angioedema type II\u2014a study of two families","volume":"2","author":"Sol\u00e9","year":"1992","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1398-9995.2010.02433.x","article-title":"Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients","volume":"66","author":"Zanicheli","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.01.003_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2007.09.025","article-title":"Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients","volume":"198","author":"Sz\u00e9gedi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.anai.2015.01.003_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2004.12.1130","article-title":"Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema","volume":"115","author":"Sz\u00e9plaki","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","article-title":"Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients","volume":"99","author":"Cicardi","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2007.06.037","article-title":"Hereditary angioedema: safety of long-term stanozolol therapy","volume":"120","author":"Sloane","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib32","first-page":"44","article-title":"Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema","volume":"1351","author":"Andriole","year":"1986","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.anai.2015.01.003_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.anai.2015.01.003_bib35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","article-title":"Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema","volume":"353","author":"Bork","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2015.01.003_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","article-title":"Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema","volume":"36","author":"Bork","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.anai.2015.01.003_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0091-6749(91)90120-D","article-title":"Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience","volume":"87","author":"Cicardi","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000441-198207000-00001","article-title":"Hereditary angioedema: an appraisal of 104 cases","volume":"284","author":"Cicardi","year":"1982","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.anai.2015.01.003_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(83)90034-9","article-title":"Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives","volume":"72","author":"Cicardi","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1473-0502(03)00164-2","article-title":"How do we treat patients with hereditary angioedema","volume":"29","author":"Cicardi","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.anai.2015.01.003_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00228-009-0771-z","article-title":"The effect of long-term danazol prophylaxis on liver function in hereditary angioedema: a longitudinal study","volume":"66","author":"Farkas","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.anai.2015.01.003_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0278-2391(99)90280-X","article-title":"The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures","volume":"57","author":"Farkas","year":"1999","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.anai.2015.01.003_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)76637-X","article-title":"Danazol therapy for hereditary angio-oedema in children","volume":"354","author":"Farkas","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2015.01.003_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3038.2002.01014.x","article-title":"Clinical management of hereditary angio-oedema in children","volume":"13","author":"Farkas","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib46","first-page":"603","article-title":"Danazol in the treatment of endometriosis and hereditary angio-oedema","volume":"237","author":"Hoogerbrugge","year":"1995","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.anai.2015.01.003_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1081-1206(10)60121-4","article-title":"Usefulness of abdominal ultrasonography in the follow-up of patients with hereditary C1-inhibitor deficiency","volume":"102","author":"Pedrosa","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib48","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1537-2995.2009.02230.x","article-title":"C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis","volume":"49","author":"Kreuz","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.anai.2015.01.003_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","article-title":"The long-term safety of danazol in women with hereditary angioedema","volume":"54","author":"Zurlo","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.anai.2015.01.003_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1701-2163(16)32048-5","article-title":"Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report","volume":"28","author":"Altman","year":"2006","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.anai.2015.01.003_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(98)80140-2","article-title":"Danazol therapy: an unusual aetiology of hepatocellular carcinoma","volume":"29","author":"Crampon","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.anai.2015.01.003_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2340\/00015555-0057","article-title":"Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema","volume":"86","author":"Helsing","year":"2006","journal-title":"Acta Derm Venereol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2015.01.003_bib53","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1007\/s12029-012-9402-5","article-title":"Danazol-induced hepatocellular carcinoma in a patient with hereditary angioedema","volume":"43","author":"Thoufeeq","year":"2012","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.anai.2015.01.003_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","article-title":"Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group","volume":"67","author":"Cicardi","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.01.003_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2500\/aap.2013.34.3702","article-title":"Assessment of hereditary angioedema treatment risks","volume":"34","author":"Kalaria","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2015.01.003_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1710-1492-10-50","article-title":"Canadian hereditary angioedema guideline","volume":"10","author":"Betschel","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.anai.2010.12.012","article-title":"Current medical management of hereditary angioedema: results from a large survey of US physicians","volume":"106","author":"Riedl","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib58","doi-asserted-by":"crossref","unstructured":"Riedl M, Banerji A, Gower R. Current medical management of hereditary angioedema: follow-up survey of US physicians [published online November 18, 2014]. J Allergy Clin Immunol Pract. http:\/\/dx.doi.org\/10.1016\/j.jaip.2014.08.017.","DOI":"10.1016\/j.jaip.2014.08.017"},{"key":"10.1016\/j.anai.2015.01.003_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.anai.2012.10.008","article-title":"International consensus on hereditary and acquired angioedema","volume":"109","author":"Lang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.01.003_bib60","series-title":"Cinryze (human C1-esterase inhibitor) [prescribing Information]","year":"2012"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:12:44Z","timestamp":1761052364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120615000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1081120615000344"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2015.01.003","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical appraisal of androgen use in hereditary angioedema: a\u00a0systematic review","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}